Acute transient phlebitis during eptifibatide intravenous injection: case report.
We present a 56-year-old man who developed acute transient phlebitis of the right cephalic vein during an intravenous injection of eptifibatide (Integrilin, Schering Plough, Kenilworth, NJ). The eptifibatide injections were discontinued, and signs of phlebitis disappeared within minutes. The patient's course was uneventful, and he was discharged home after 8 days. As far as we know, this is the first report of acute transient phlebitis during intravenous eptifibatide injections in the English-language medical literature.
Hay
Emile
E
Quality Control and Risk Management Unit, Barzilai Medical Center, Ben-Gurion University of the Negev, Ashkelon, Israel.
Blaer
Yossef
Y
Shlyakhover
Vladimir
V
Katz
Amos
A
Jafari
Jamal
J
D000208:Acute Disease; D001132:Arm / Q000098:blood supply; D000077542:Eptifibatide; D006801:Humans; D007262:Infusions, Intravenous / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000008:administration & dosage / Q000009:adverse effects*; D010689:Phlebitis / Q000139:chemically induced*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D013997:Time Factors; D014680:Veins
D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D000077542:Eptifibatide